Christopher A. Marlett, Director at Cue Biopharma, Inc. (CUE), sold 24,700 shares at $15.71 ($402K) on 2019-12-31, disclosed to the SEC on 2019-12-31.
Open-market sale of $402k CUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.24 | 9,000 | $155K | 38.6% |
| 2 | $15.71 | 9,000 | $141K | 35.2% |
| 3 | $15.77 | 6,700 | $106K | 26.3% |
| Total | $16.28 avg | 24,700 | $402K | 100% |
| Filing → |
| MDBH | BUY | 2025-10-07 | $14K | — | Filing → |
| MDBH | BUY | 2025-08-29 | $11K | — | Filing → |
| MDBH | BUY | 2025-08-27 | $13K | — | Filing → |